Samantha Fraser‐Bell

The University of Sydney — Australia

Medicine · Health Sciences

40h-index6.3kcitations167works11.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(123), Retinal Imaging and Analysis(98), Retinal and Optic Conditions(69), Glaucoma and retinal disorders(43), Ocular Diseases and Behçet’s Syndrome(35)

Publications163 total

Imaging and functional correlates of fibrosis in neovascular age-related macular degeneration: a systematic review
Frontiers in Ophthalmology·2026Open Access
Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy
JAMA Ophthalmology·2025Open Access
Twelve‐Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry
Clinical and Experimental Ophthalmology·2025
Lost to Follow-Up in Neovascular Age-Related Macular Degeneration: A Systematic Review of Global Trends, Risk Factors, and Clinical Consequences
Ophthalmologica·2025
A prospective, open-label, single-arm, investigator-initiated clinical trial to assess the efficacy, safety and durability of faricimab in patients with inadequate response to current treatment for neovascular age-related macular degeneration: protocol design and rationale for the FURGGHORN Study
BMJ Open Ophthalmology·2025Open Access
Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review
Survey of Ophthalmology·2025
Baseline OCT Biomarkers Associated with Visual Acuity in Diabetic Macular Edema
Ophthalmology·2025· 1 cited
Real‐World 10‐Year Outcomes of Anti‐<scp>VEGF</scp> Therapy for Neovascular Age‐Related Macular Degeneration: A Meta‐Analysis
Clinical and Experimental Ophthalmology·2025· 4 citedOpen Access
Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema
Ophthalmology Retina·2025· 5 citedOpen Access
Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion
Ophthalmology Retina·2024· 2 cited
One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity
Ophthalmology Retina·2024· 3 citedOpen Access
TENAYA and LUCERNE
Ophthalmology·2024· 127 citedOpen Access
Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study
BMJ Open Ophthalmology·2023· 18 citedOpen Access
Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen
Eye·2023· 11 citedOpen Access
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Eye·2023· 5 citedOpen Access
Management of macular oedema due to retinal vein occlusion: An evidence‐based systematic review and meta‐analysis
Clinical and Experimental Ophthalmology·2023· 14 citedOpen Access
Update on Retinal Vein Occlusion
Asia-Pacific Journal of Ophthalmology·2023· 85 citedOpen Access
Diabetic Macular Oedema Guidelines: An Australian Perspective
Journal of Ophthalmology·2023· 8 citedOpen Access
Reply
Ophthalmology Retina·2022· 1 cited
Reactivation of Multifocal Choroiditis Associated with Treatment in Latent Tuberculosis
Case Reports in Ophthalmology·2022· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Mark C. Gillies(19), Dinah Zur(8), Matías Iglicki(8), Catharina Busch(8), Anat Loewenstein(8), Jay Chhablani(8), Rohit Varma(8), Zafer Cebeci(7), Marco Lupidi(7), Daniel Barthelmes(7), Godfrey Quin(6), Lyndell L. Lim(6), Voraporn Chaikitmongkol(6), Ronald Klein(6), Vuong Nguyen(6), Anna Campain(5), Ian L. McAllister(5), Alessandro Invernizzi(5), Ermete Giancipoli(5), Matúš Rehák(5)